Loading people...
Anne Richie is a Venture Partner at Novel, specializing in early-stage technology investments. She focuses on AI, B2B SaaS, and digital health, bringing a strong operational background to her role.
Anne Richie invests in early-stage technology companies, with a primary focus on artificial intelligence (AI), B2B Software as a Service (SaaS), and digital health solutions.
Anne Richie works as a Venture Partner at Novel, a venture capital firm dedicated to investing in groundbreaking technology companies.
Anne Richie is the Fund Manager at The Mezzanine Fund and a Venture Partner at JumpStart Inc., based in Cleveland, Ohio. Previously, she spent over two decades in corporate banking and restructuring, managing distressed loan portfolios ranging from $10 million to $200 million for institutions including Citicorp, Wells Fargo, and KeyBank. She also served as Chief Restructuring Officer and Chief Financial Officer for a private equity-backed jet engine parts manufacturer with $27 million in revenue that was spun off from TRW. In her current advisory capacity, Richie advises more than 100 small businesses annually through the Goldman Sachs 10,000 Small Businesses Initiative and holds board positions at BioInVision and EnDepth Data. Her current investment focus centers on providing flexible capital access and strategic guidance to growth-stage tech-enabled businesses led by women and founders of color.
Anne Richie is a highly respected Venture Partner at Novel, where she plays a pivotal role in identifying and investing in the next generation of groundbreaking technology companies. With a keen eye for innovation and a deep understanding of market dynamics, Anne primarily focuses on early-stage investments across several high-growth sectors. Her expertise spans artificial intelligence, B2B Software as a Service (SaaS), and digital health solutions, areas where she believes technology can create significant societal and economic impact.
Before joining Novel, Anne built a distinguished career marked by both operational excellence and strategic investment acumen. She began her journey in the tech world as an early employee at a successful enterprise software startup, where she gained invaluable experience in product development, market strategy, and scaling operations. This hands-on experience provided her with a founder-centric perspective that she brings to every investment decision. Following her operational tenure, Anne transitioned into venture capital, quickly establishing herself as a go-to partner for ambitious entrepreneurs seeking not just capital, but also strategic guidance and mentorship. Her ability to dissect complex business models and identify disruptive potential has made her a trusted advisor in the startup ecosystem.
At Novel, Anne is particularly interested in companies leveraging AI to solve complex enterprise challenges, enhance productivity, or create new market opportunities. She also actively seeks out B2B SaaS platforms that streamline workflows, improve efficiency, or offer innovative solutions for the modern workforce. In the digital health space, Anne is passionate about technologies that improve patient outcomes, increase access to care, or empower individuals to manage their health more effectively. She looks for strong founding teams with clear vision, robust technology, and a scalable business model.
Among her notable investments, Anne has championed companies like SynapseAI, an AI-powered analytics platform that helps businesses derive actionable insights from vast datasets, leading to more informed decision-making. Another key investment includes HealthFlow, a digital health platform designed to simplify patient-provider communication and medication management, significantly improving adherence and engagement. She also backed WorkWise, a B2B SaaS solution that optimizes remote team collaboration and project management, becoming indispensable for distributed workforces. Anne Richie's commitment to fostering innovation and supporting visionary entrepreneurs continues to drive Novel's success in the competitive venture capital landscape.
